WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.
WHAT: AAPS is pleased to present the workshop on Strategies to Address Therapeutic Protein Drug Interactions during Clinical Development. This event will feature a review of pre-clinical tools, test systems, and relevant documented Therapeutic Protein (TP)-drug interactions. Case studies, study designs, and acceptance criteria for certain interactions in clinical studies will be addressed.
WHY: The purpose of this workshop is to provide participants with a clear understanding of how to develop strategies for the assessment of TP-drug interactions. This session will provide the opportunity for participants to interact with industry, academic, and regulatory representatives, and to participate in roundtable discussions on how to arrive at science-driven, risk-based approaches for assessing the potential for TP-drug interactions.
WHEN/WHERE: May 15-16, 2010
Hilton San Francisco Union Square
San Francisco, CA
|Contact: Joseph Catapano|
American Association of Pharmaceutical Scientists